The Development of Preventives and Therapeutics for Alzheimer's Disease that Inhibit the Formation of &bgr;-Amyloid Fibrils (fA&bgr;), as Well as Destabilize Preformed fA&bgr;

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4357-4375

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of &bgr;-Amyloid Protein in Synaptic Function: Implications for Alzheimer's Disease Therapy

By  

Current Neuropharmacology, Vol. 4, Iss. 2, 2006-04 ,pp. : 149-163

Bentham Science Publishers

Access to resources Recommend Favorite

-Amyloid Disrupting Drugs: Potential in the Treatment of Alzheimer's Disease

By Soto C.  

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

Fluorine-18 Radiolabeled Heterocycles as PET Tracers for Imaging &bgr;- Amyloid Plaques in Alzheimer’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-04 ,pp. : 909-919

Bentham Science Publishers

Access to resources Recommend Favorite

Intracellular Amyloid &bgr;-Protein and Its Associated Molecules in the Pathogenesis of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1075-1080

Bentham Science Publishers

Access to resources Recommend Favorite